Gralise™ (gabapentin) Tablets, for the management of post-herpetic neuralgia (PHN)

PLEASE CLICK ON THE LINK BELOW TO FIND INFORMATION ABOUT GRALISE™.

Full prescribing and safety information can be found at www.gralise.com.

U.S. commercialization of Gralise™ commenced in October 2011.
Gralise™ is marketed by Depomed, Inc. in the United States.

If you have any questions regarding our marketing products, please call 1.866.458.6389.